Confluent and reticulate papillomatosis: response to topical calcipotriol

• Published in: The Journal of dermatological treatment Vol. 11; no. 2; pp. 109 - 111
• Main Authors: Bayramgürler, D, Apaydin, R, Bilen, N, Müezzinoglu, B
• Format: Journal Article
• Language: English
• Published: Oslo Informa UK Ltd 2000; Taylor & Francis
• Subjects: Biological and medical sciences; Confluent And Reticulate Papillomatosis Topical Calcipotriol; Medical sciences; Pharmacology. Drug treatments; Skin, nail, hair, dermoskeleton; Case study; Human; Skin disease; Chemotherapy; Treatment; Vitamin D; Analog; Confluent and reticulate papillomatosis Gougerot Carteaud; Calcipotriol; Benign neoplasm; Ointment; Percutaneous route
• ISSN: 0954-6634; 1471-1753
• DOI: 10.1080/09546630050517513

Confluent and reticulate papillomatosis of Gougerot and Carteaud (CRP) is a rare dermatosis that is probably a disorder of keratinization. Calcipotriol, a vitamin D analogue, regulates keratinocyte differentiation and proliferation. We describe a 21 year old woman who was diagnosed as having CRP and was treated with topical calcipotriol ointment twice daily. A marked clinical improvement was achieved after 2 months of treatment. In conclusion we suggest that topical calcipotriol, when used at a safe dose, is a ligitamate treatment for CRP and offers an alternative to oral vitamin A. (J Dermatol Treat (2000) 11:109-111)